LRRK2-IN1

LRRK2-IN1 : Inhibitor of LRRK2

Structure

Information

  • LRRK2 (Mutant:WT, G2019S)
  • Inhibitor
  • up to 3 uM
  • Reviewer recommended concentration: 10-20 µM

In Vitro Validations

Uniprot ID: Q5S007
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 6 nM
Potency Assay: Enzymatic activity of GST-LRRK2[G2019S] (1,326–2,527)
PDB ID for probe-target interaction (3D structure): 5OOT 5OQ5 5OQ6 5VBO 5WA5 7L9K 7LEM 4YZM
Target aliases:
Leucine-rich repeat serine/threonine-protein kinas ...

DOI Reference: 10.1038/nchembio.538

Uniprot ID: Q5S007
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 13 nM
Potency Assay: Enzymatic activity of GST-LRRK2 (1,326–2,527)
PDB ID for probe-target interaction (3D structure): 5OOT 5OQ5 5OQ6 5VBO 5WA5 7L9K 7LEM 4YZM
Target aliases:
Leucine-rich repeat serine/threonine-protein kinas ...

DOI Reference: 10.1038/nchembio.538

Uniprot ID: Q5S007
Target Class: Kinase
Target SubClass: TKL
Potency: Kd
Potency Value: 20 nM
Potency Assay: Binding Assay (Ambit)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Leucine-rich repeat serine/threonine-protein kinas ...

DOI Reference: 10.1038/nchembio.538

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Off Target: DCLK2
Potency end-point : IC50 45 nM
Potency assay (off target): LRRK2-IN-1 inhibits only 12 kinases among the Ambit 442 diverse kinases panel with a score of less than 10% of the DMSO control at a concentration of 10 μM. (Kinase-binding assays against a panel of 442 distinct kinases using the KINOMEscan methodology (Ambit Biosciences). Radioactivity-based enzymatic assays against a panel of 105 kinases (Dundee profiling) The selectivity score (S (3 μM)) for LRRK2-IN-1, calculated by dividing the number of kinases found to bind with a dissociation constant (Kd < 3 μM) by the total number of kinases tested, is 0.029 (13/442), which represents high selectivity
Potency assay, off target (cells): Activity-based proteomics against 260 kinases using the KiNativ technology (ActivX Biosciences). the selectivity of LRRK2-IN-1 was performed by profiling directly against all kinases detectable in human peripheral blood mononuclear cells (hPBMC, 180 kinases) and mouse brain tissue (195 kinases) using KiNativ.
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating
In Model Organisms

(last updated: 21 Feb 2023 )